Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

CRISPR Screening Reveals How Genetic Variants Drive Neurodegenerative Risk

Researchers studying human induced pluripotent stem cell-derived microglia-like cells showed how genetic variants can impact cell behavior and used CRISPR gene editing to show how one gene’s effect depends on its cellular context. The post CRISPR Screening Reveals How Genetic Variants Drive Neurodegenerative Risk appeared first on GEN - Genetic Engineering and Biotechnology News .

Scientists at the Wellcome Sanger Institute and Open Targets have developed a method to connect genetic variants linked to neurodegenerative diseases, such as Alzheimer's, with their impact on specific cell functions. The team differentiated human induced pluripotent stem cells into microglia-like cells, which are immune cells responsible for clearing debris and misfolded proteins in the brain.

Using CRISPR gene editing, the researchers discovered that the effect of a genetic mutation depends on the cell type and its environment, which is crucial for designing targeted therapies. The study, published in Nature Genetics, found that genetic variants can have opposite effects on cell behavior depending on the specific cell type and context, highlighting the importance of cellular context in understanding genetic risks.

This research provides a framework for translating genetic risk variants into biological insights, offering a scalable blueprint for studying brain immune cells and potentially identifying new pathways and drug targets for neurodegenerative disorders.

Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at genengnews.com →

More in Health & Medicine

More from Wednesday 18 November →